Conditional cell suicide using dox-dependent caspase-2 expression

Journal of Gene Medicine

Volumn 5, Issue 4, 2003, Pages 343-354

  Knott, Anja ^a   Müller, Yvonne ^a,b   Zunino, Susan J ^a   Berens, Christian ^a   Hillen, Wolfgang ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Adoptive immune transfer; Apoptosis; Doxycycline

Indexed keywords

CASPASE 2; DOXYCYCLINE; GANCICLOVIR; REGULATOR PROTEIN; THYMIDINE KINASE; ACYL COENZYME A DESATURASE; ARABIDOPSIS PROTEIN; CASP3 PROTEIN, HUMAN; CASP3 PROTEIN, MOUSE; CASPASE; CASPASE 3; COMPLEMENTARY DNA; DNA; FAD7 PROTEIN, ARABIDOPSIS; PROTEIN SERINE THREONINE KINASE; RECEPTOR INTERACTING PROTEIN SERINE THREONINE KINASE; RECEPTOR INTERACTING PROTEIN SERINE THREONINE KINASE 2; RIPK2 PROTEIN, HUMAN; RIPK2 PROTEIN, MOUSE;

ADOPTIVE TRANSFER; APOPTOSIS; ARTICLE; CELL DEATH; CELL LINE; CELL SURVIVAL; CELL TRANSFER; CELL VIABILITY; CONTROLLED STUDY; CULTURE MEDIUM; GENE CONSTRUCT; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENE TARGETING; GENETIC CODE; GENETIC TRANSFECTION; HELA CELL; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; IMMUNOLOGY; MOLECULAR CLONING; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SUICIDE TRANSGENE; TOXICOLOGY; ANIMAL; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOUSE; PHYSIOLOGY;

ANIMALS; APOPTOSIS; ARABIDOPSIS PROTEINS; CASPASE 2; CASPASE 3; CASPASES; CELL DEATH; CELL LINE; CELL SURVIVAL; DNA; DNA, COMPLEMENTARY; DOXYCYCLINE; FATTY ACID DESATURASES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HELA CELLS; HUMANS; MICE; PROTEIN-SERINE-THREONINE KINASES; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASE 2; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASES; TRANSFECTION;

EID: 14644410351     PISSN: 1099498X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jgm.342     Document Type: Article

References (35)

1. Gossen M, Bujard H. Tetracyclines in the control of gene expression in eukaryotes. In: Tetracyclines in Biology, Chemistry and Medicine, Nelson M, Hillen W, Greenwald RA (eds). Birkhäuser Verlag: Berlin, 2001; 139-157.
2. Gossen M, Bonin AL, Bujard H. Control of gene activity in higher eukaryotic cells by prokaryotic regulatory elements. Trends Biochem Sci 1993; 18: 471-475.
3. Deuschle U, Meyer WK, Thiesen HJ. Tetracycline-reversible silencing of eukaryotic promoters. Mol Cell Biol 1995; 15: 1907-1914.
4. Gossen M, Freundlieb S, Bender G, et al. Transcriptional activation by tetracyclines in mammalian cells. Science 1995; 268: 1766-1769.
5. Forster K, Helbl V, Lederer T, et al. Tetracycline-inducible expression systems with reduced basal activity in mammalian cells. Nucleic Acids Res 1999; 27: 708-710.
6. Freundlieb S, Schirra-Müller C, Bujard H. A tetracycline controlled activation/repression system with increased potential for gene transfer into mammalian cells. J Gene Med 1999; 1: 4-12.
7. Urlinger S, Baron U, Thellmann M, et al. Exploring the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity. Proc Natl Acad Sci U S A 2000; 97: 7963-7968.
8. Urlinger S, Helbl V, Guthmann J, et al. The p65 domain from NF-kappaB is an efficient human activator in the tetracycline-regulatable gene expression system. Gene 2000; 247 103-110.
9. Knott A, Garke K, Urlinger S, et al. Tetracycline-dependent gene regulation: combinations of transregulators yield a variety of expression windows. Biotechniques 2002; 32 796-806.
10. McCarthy JV, Ni J, Dixit VM. RIP2 is a novel NF-kappaB-activating and cell death-inducing kinase. J Biol Chem 1998; 273: 16968-16975.
11. Boldin MP, Varfolomeev EE, Pancer Z, et al. A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain. J Biol Chem 1995; 270: 7795-7798.
12. Chinnaiyan AM, O'Rourke K, Tewari M, et al. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 1995; 81: 505-512.
13. Muzio M, Stockwell BR, Stennicke HR, et al. An induced proximity model for caspase-8 activation. J Biol Chem 1998; 273 2926-2930.
14. Duan H, Dixit VM. RAIDD is a new 'death' adaptor molecule. Nature 1997; 385: 86-89.
15. Uren AG, Pakusch M, Hawkins CJ, et al. Cloning and expression of apoptosis inhibitory protein homologs that function to inhibit apoptosis and/or bind tumor necrosis factor receptor-associated factors. Proc Natl Acad Sci U S A 1996; 93: 4974-4978.
16. Colussi PA, Harvey NL, Kumar S. Prodomain-dependent nuclear localization of the caspase-2 (Nedd2) precursor. A novel function for a caspase prodomain. J Biol Chem 1998; 273: 24 535-24 542.
17. Colussi PA, Harvey NL, Shearwin-Whyatt LM, et al. Conversion of procaspase-3 to an autoactivating caspase by fusion to the caspase-2 prodomain. J Biol Chem 1998; 273: 26 566-26 570.
18. Baron U, Freundlieb S, Gossen M, et al. Co-regulation of two gene activities by tetracycline via a bidirectional promoter. Nucleic Acids Res 1995; 23: 3605-3606.
19. Tewari M, Quan LT, O'Rourke K, et al. Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell 1995; 81 801-809.
20. Gossen M, Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci U S A 1992; 89: 5547-5551.
21. Unger B, Klock G, Hillen W. Nucleotide sequence of the repressor gene of the RA1 tetracycline resistance determinant: structural and functional comparison with three related Tet repressor genes. Nucleic Acids Res 1984; 12: 7693-7703.
22. Thomis DC, Marktel S, Bonini C, et al. A Fas-based suicide switch in human T cells for the treatment of graft-versus-host disease. Blood 2001; 97: 1249-1257.
23. Kolb HJ, Mittermüller J, Clemm C, et al. Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood 1990; 76: 2462-2465.
24. Slavin S, Naparstek E, Nagler A, et al. Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes. Exp Hematol 1995; 23: 1553-1562.
25. Or R, Ackerstein A, Nagler A, et al. Allogeneic cell-mediated and cytokine-activated immunotherapy for malignant lymphoma at the stage of minimal residual disease after autologous stem cell transplantation. J Immunother 1998; 21: 447-453.
26. Bonini C, Ferrari G, Verzeletti S, et al. HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia. Science 1997; 276: 1719-1724.
27. Vogel JU, Scholz M, Cinatl J Jr. Treatment of cytomegalovirus diseases. Intervirology 1997; 40: 357-367.
28. Butt AJ, Harvey NL, Parasivam G, et al. Dimerization and autoprocessing of the Nedd2 (caspase-2) precursor requires both the prodomain and the carboxyl-terminal regions. J Biol Chem 1998; 273: 6763-6768.
29. Izumi M, Gilbert DM. Homogeneous tetracycline-regulatable gene expression in mammalian fibroblasts. J Cell Biochem 1999; 76: 280-289.
30. Verzeletti S, Bonini C, Marktel S, et al. Herpes simplex virus thymidine kinase gene transfer for controlled graft-versus-host disease and graft-versus-leukemia: clinical follow-up and improved new vectors. Hum Gene Ther 1998; 9: 2243-2251.
31. Paulus W, Baur I, Boyce FM, et al. Self-contained, tetracycline-regulated retroviral vector system for gene delivery to mammalian cells. J Virol 1996; 70: 62-67.
32. Dugray A, Geay JF, Foudi A, et al. Rapid generation of a tetracycline-inducible BCR-ABL defective retrovirus using a single autoregulatory retroviral cassette. Leukemia 2001; 15: 1658-1662.
33. Hwang JJ, Scuric Z, Anderson WF. Novel retroviral vector transferring a suicide gene and a selectable marker gene with enhanced gene expression by using a tetracycline-responsive expression system. J Virol 1996; 70: 8138-8141.
34. Watsuji T, Okamoto Y, Emi N, et al. Controlled gene expression with a reverse tetracycline-regulated retroviral vector (RTRV) system. Biochem Biophys Res Commun 1997; 234: 769-773.
35. Martin DA, Siegel RM, Zheng L, et al. Membrane oligomerization and cleavage activates the caspase-8 (FLICE/MACHalphal) death signal. J Biol Chem 1998; 273: 4345-4349.